Radiology News
Get the latest on radiology with press releases highlighting research, innovations, and advancements shaping medical imaging and diagnostics. Stay informed on key developments in radiology and explore opportunities in imaging technology and patient care.
Dec 15, 2025 at 7:05 AM
NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics announced that Natera has voluntarily withdrawn its appeal in ongoing RaDaR patent litigation....
Dec 11, 2025 at 5:30 PM
Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect® MRD Test in Early Triple-Negative Breast Cancer at SABCS
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the first clinical study results from its Oncodetect® molecular residual disease (MRD) test in breast cancer. Findings from the NSABP B-59 substudy, conducted in collaboration with the NSABP Foundation and the German Breast Group (GBG), demonstrated that the Oncodetect test strongly predicts distant recurrence following surgery in patients with early...
Dec 11, 2025 at 8:20 AM
Summit Radiology Contracts with Healthcare Administrative Partners for Comprehensive Revenue Cycle Management Services
MEDIA, Pa.--(BUSINESS WIRE)--Healthcare Administrative Partners (HAP), a leading provider of outsourced billing, coding, and practice management solutions for radiology practices, today announces the addition of Summit Radiology in Fort Wayne, IN to its roster of revenue cycle management clients. Summit Radiology is the largest and most progressive full-service diagnostic and interventional radiology group in the region, providing services at over 40 outpatient and hospital locations in northea...
Dec 10, 2025 at 3:00 AM
Sainte Catherine, Institut du Cancer Avignon-Provence (ICAP), Becomes the First Center in Europe to Implement the Varian Latest Halcyon Advancements with Identify integration, PerfectKinetix Dynamic Couch and HyperSight for Personalized Radiotherapy
AVIGNON, France--(BUSINESS WIRE)--Institut du Cancer Avignon-Provence (ICAP), and Varian, a Siemens Healthineers company, announced today the first European installation of the Halcyon version 5.0 radiotherapy platform, combined with IDENTIFY real-time motion management, and the PerfectKinetix Dynamic Couch. This milestone marks a significant step forward in delivering more precise, efficient, and personalized radiotherapy, while enhancing the overall patient experience. The latest evolution of...
Dec 9, 2025 at 7:00 AM
NVision Metabolic MRI Technology Advances Oncology Research
ULM, Germany--(BUSINESS WIRE)--Memorial Sloan Kettering Cancer Center using NVision’s quantum-based MRI technology to advance research for more rapid cancer diagnosis and treatment....
Dec 8, 2025 at 1:09 PM
Flashpoint Therapeutics’ Scientific Founder Chad A. Mirkin Awarded the Prestigious Harvey Prize
EVANSTON, Ill.--(BUSINESS WIRE)--Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicines, today congratulates its scientific co-founder, Professor Chad A. Mirkin, on being awarded the Harvey Prize in Science and Technology. The prestigious international prize, awarded by the Technion, Israel Institute of Technology in Haifa, recognizes Professor Mirkin for groundbreaking discoveries that have fundamentally reshaped the fields of nanoscience and nanote...
Dec 8, 2025 at 11:45 AM
Median Technologies Partners With Leading U.S. Healthcare Company to Bring eyonis® LCS to Patients Across the U.S. and Europe
SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, “Median” or the “Company”), manufacturer of eyonis® , a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer diagnosis, and a globally leading provider of AI-based image analyses and central imaging services for oncology drug developers, today announced the signing of a non-exclusive global commercial distribution agreement...
Dec 8, 2025 at 8:00 AM
AdvanCell Receives First Delivery of High-Activity Thorium-228, Highlighting a Unique Industry Capability and Expertise Essential to Scaling Lead-212 Production for Targeted Alpha Therapies
SYDNEY & BOSTON--(BUSINESS WIRE)--AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, today announced it has received the first delivery of high-activity 228Th, the parent isotope of 212Pb and a key starting material to produce the alpha-emitter 212Pb, used to manufacture ADVC001, the company’s lead asset, and other 212Pb-based radioligand therapies in the pipeline. This delivery marks a major milestone for the company and underscor...
Dec 4, 2025 at 3:15 PM
Open Letter to SNMMI Board of Directors and President Dr. Prabhu Ethiraj: TeamBest Global Calls for Strengthened Collaboration to Advance Theranostics and Expand Cancer Diagnosis and Treatment Options
WASHINGTON--(BUSINESS WIRE)--Dr. Krishnan Suthanthiran, President/Founder of TeamBest Global (TBG) companies and the International Society for Radiation Medicine & Molecular Imaging (ISRMMI), is urging closer collaboration with the Society of Nuclear Medicine and Molecular Imaging (SNMMI) to accelerate the adoption of theranostics and broaden treatment options for cancer patients worldwide. TBG has long been recognized for developing cost-effective, innovative technologies, and advanced the...
Dec 4, 2025 at 5:14 AM
Orano Med Enters Next Phase of Collaboration With Roche
CHÂTILLON, France--(BUSINESS WIRE)--Orano Med's collaboration with Roche to develop “two-step pretargeted radioimmunotherapy” (or PRIT) ready to advance into clinical development....
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.